Another interesting stat here that was reported by Oncosil today. Overall survival with the PanCo study is 16.1 months but that data point was taken at May 2019. With almost another year and the study to be completed in June 2020, expect to see the OS to increase beyond 16.1 months.
Cheers
GW
Ann: Oncosil breakthrough device receives CE Marking approval, page-78
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.3¢ |
Change
-0.001(7.14%) |
Mkt cap ! $49.19M | |||
| Open | High | Low | Value | Volume |
| 1.4¢ | 1.4¢ | 1.3¢ | $130.8K | 9.987M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 7940120 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 1171596 | 5 |
View Market Depth
| Last trade - 12.03pm 17/10/2024 (20 minute delay) ? |
| OSL (ASX) Chart |